These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 28590461)

  • 1. Advances in lymphoma and leukemia from the 2016 American Society of Hematology annual meeting and exposition.
    Clin Adv Hematol Oncol; 2017 Mar; 15 Suppl 3(3):1-24. PubMed ID: 28590461
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent advances in the treatment of leukemia, lymphoma, and myeloma. [Review of Selected Presentations From the 52nd American Society of Hematology Annual Meeting and Exposition. December 4–7, 2010. Orlando, Florida].
    Cheson BD
    Clin Adv Hematol Oncol; 2011 Apr; 9(4 Suppl 7):1-24. PubMed ID: 21558999
    [No Abstract]   [Full Text] [Related]  

  • 3. Advances in lymphoma and leukemia from the 2016 American Society of Hematology annual meeting and exposition: Commentary.
    Fowler NH
    Clin Adv Hematol Oncol; 2017 Mar; 15 Suppl 3(3):21-23. PubMed ID: 28590462
    [No Abstract]   [Full Text] [Related]  

  • 4. Highlights in leukemia and lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 11(3):1-20. PubMed ID: 33843915
    [No Abstract]   [Full Text] [Related]  

  • 5. Highlights in leukemia and lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Barr PM
    Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 11(3):17-19. PubMed ID: 33843916
    [No Abstract]   [Full Text] [Related]  

  • 6. American Society of Hematology--51st annual meeting & exposition. Part 1.
    Shumoogam J; Beecher N
    IDrugs; 2010 Feb; 13(2):57-9. PubMed ID: 20127549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in aggressive lymphoma from the 2017 American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2018 Feb; 16 Suppl 5(2):1-24. PubMed ID: 29742097
    [No Abstract]   [Full Text] [Related]  

  • 8. Advances in chronic lymphocytic leukemia from the 63rd American Society of Hematology Annual Meeting and Exposition: commentary.
    Coombs CC
    Clin Adv Hematol Oncol; 2022 Feb; 20 Suppl 7(2):15-19. PubMed ID: 35343945
    [No Abstract]   [Full Text] [Related]  

  • 9. Advances in aggressive lymphoma from the 2017 American Society of Hematology Annual Meeting and Exposition: commentary.
    Locke FL; Haroun F
    Clin Adv Hematol Oncol; 2018 Feb; 16 Suppl 5(2):19-23. PubMed ID: 29742098
    [No Abstract]   [Full Text] [Related]  

  • 10. Highlights in lymphoma from the 2014 American Society of Hematology annual meeting and exposition.
    Clin Adv Hematol Oncol; 2015 Feb; 13(2 Suppl 2):1-23. PubMed ID: 25775207
    [No Abstract]   [Full Text] [Related]  

  • 11. Highlights in leukemia and lymphoma from the 63rd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2022 Feb; 20 Suppl 7(2):1-20. PubMed ID: 35343944
    [No Abstract]   [Full Text] [Related]  

  • 12. Highlights in lymphoma from the 2016 American Society of Hematology annual meeting and exposition: Commentary.
    Horwitz SM
    Clin Adv Hematol Oncol; 2017 Feb; 15 Suppl 1(2):20-23. PubMed ID: 28590460
    [No Abstract]   [Full Text] [Related]  

  • 13. Highlights in lymphoma from the 2012 American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2013 Feb; 11(2 Suppl 3):6-23. PubMed ID: 23604200
    [No Abstract]   [Full Text] [Related]  

  • 14. Highlights in Hodgkin lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 7(2):1-24. PubMed ID: 33843921
    [No Abstract]   [Full Text] [Related]  

  • 15. Highlights in Hodgkin lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Evens AM
    Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 7(2):20-23. PubMed ID: 33843922
    [No Abstract]   [Full Text] [Related]  

  • 16. Highlights in T-cell lymphoma From the 2013 American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2014 Feb; 12 Suppl 5(2):6-18. PubMed ID: 25856173
    [No Abstract]   [Full Text] [Related]  

  • 17. Highlights in lymphoma from the 2017 American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2018 Feb; 16 Suppl 3(2):1-24. PubMed ID: 29742095
    [No Abstract]   [Full Text] [Related]  

  • 18. Highlights in lymphoma from the 2013 American Society of Hematology Annual Meeting and Exposition: commentary.
    Bartlett NL
    Clin Adv Hematol Oncol; 2014 Feb; 12 Suppl 6(2):18-23. PubMed ID: 25856285
    [No Abstract]   [Full Text] [Related]  

  • 19. Highlights in lymphoma from the 2013 American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2014 Feb; 12 Suppl 6(2):3-18. PubMed ID: 25856284
    [No Abstract]   [Full Text] [Related]  

  • 20. Highlights in T-cell lymphoma From the 2013 American Society of Hematology Annual Meeting and Exposition: commentary.
    Horwitz SM
    Clin Adv Hematol Oncol; 2014 Feb; 12 Suppl 5(2):19-22. PubMed ID: 25856174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.